These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35339342)

  • 1. Excitability properties of mouse and human skeletal muscle fibres compared by muscle velocity recovery cycles.
    Suetterlin KJ; Männikkö R; Matthews E; Greensmith L; Hanna MG; Bostock H; Tan SV
    Neuromuscul Disord; 2022 Apr; 32(4):347-357. PubMed ID: 35339342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties.
    Witt A; Bostock H; Z'Graggen WJ; Tan SV; Kristensen AG; Kristensen RS; Larsen LH; Zeppelin Z; Tankisi H
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32150167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloride channels in myotonia congenita assessed by velocity recovery cycles.
    Tan SV; Z'Graggen WJ; Boërio D; Rayan DR; Norwood F; Ruddy D; Howard R; Hanna MG; Bostock H
    Muscle Nerve; 2014 Jun; 49(6):845-57. PubMed ID: 24037712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis.
    Tan SV; Suetterlin K; Männikkö R; Matthews E; Hanna MG; Bostock H
    Clin Neurophysiol; 2020 Apr; 131(4):816-827. PubMed ID: 32066100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle velocity recovery cycles in neurogenic muscles.
    Witt A; Kristensen RS; Fuglsang-Frederiksen A; Pedersen TH; Finnerup NB; Kasch H; Tankisi H
    Clin Neurophysiol; 2019 Sep; 130(9):1520-1527. PubMed ID: 31295721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle velocity recovery cycles: Comparison between surface and needle recordings.
    Z'graggen WJ; Trautmann JP; Boërio D; Bostock H
    Muscle Nerve; 2016 Feb; 53(2):205-8. PubMed ID: 26044702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo assessment of muscle membrane properties in myotonic dystrophy.
    Tan SV; Z'graggen WJ; Boërio D; Turner C; Hanna MG; Bostock H
    Muscle Nerve; 2016 Aug; 54(2):249-57. PubMed ID: 26789642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of muscle membrane properties in the sodium channel myotonias.
    Tan SV; Z'Graggen WJ; Hanna MG; Bostock H
    Muscle Nerve; 2018 Apr; 57(4):586-594. PubMed ID: 28877545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.
    Imbrici P; Altamura C; Camerino GM; Mangiatordi GF; Conte E; Maggi L; Brugnoni R; Musaraj K; Caloiero R; Alberga D; Marsano RM; Ricci G; Siciliano G; Nicolotti O; Mora M; Bernasconi P; Desaphy JF; Mantegazza R; Camerino DC
    FASEB J; 2016 Oct; 30(10):3285-3295. PubMed ID: 27324117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcolemmal excitability in the myotonic dystrophies.
    Boland-Freitas R; Lee J; Howells J; Liang C; Corbett A; Nicholson G; Ng K
    Muscle Nerve; 2018 Apr; 57(4):595-602. PubMed ID: 28881011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses.
    Bandschapp O; Iaizzo PA
    Paediatr Anaesth; 2013 Sep; 23(9):824-33. PubMed ID: 23802937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force training induces changes in human muscle membrane properties.
    Z'Graggen WJ; Trautmann JP; Bostock H
    Muscle Nerve; 2016 Jun; 54(1):144-6. PubMed ID: 27104654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-sensor mutations in channelopathies of skeletal muscle.
    Cannon SC
    J Physiol; 2010 Jun; 588(Pt 11):1887-95. PubMed ID: 20156847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated resting H
    Fuster C; Perrot J; Berthier C; Jacquemond V; Allard B
    J Physiol; 2017 Oct; 595(20):6417-6428. PubMed ID: 28857175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.
    Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG
    Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intermittent high-frequency stimulation on muscle velocity recovery cycle recordings.
    Hochstrasser A; Rodriguez B; Söll N; Bostock H; Z'Graggen WJ
    J Neurophysiol; 2021 Sep; 126(3):736-742. PubMed ID: 34288792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles.
    Tan SV; Z'graggen WJ; Boërio D; Rayan DL; Howard R; Hanna MG; Bostock H
    Muscle Nerve; 2012 Aug; 46(2):193-203. PubMed ID: 22806368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.